Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes

被引:0
|
作者
Chen, Tian [1 ]
Xiao, Shengjue [1 ]
Chen, Zhengdong [1 ]
Yang, Yiqing [1 ]
Yang, Bingquan [2 ]
Liu, Naifeng [1 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, Nanjing, Jiangsu, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Sch Med, Inst Diabet,Dept Endocrinol, Nanjing, Jiangsu, Peoples R China
关键词
Peripheral artery disease; Diabetic peripheral neuropathy; Risk factors; Type 2 diabetes mellitus; Lower limb complication; SERUM URIC-ACID; CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; TOTAL CHOLESTEROL; VASCULAR-DISEASE; GLYCEMIC CONTROL; CYSTATIN-C;
D O I
10.1016/j.diabres.2023.111079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To investigate the prevalence of peripheral artery disease (PAD) and diabetic peripheral neuropathy (DPN) and the associated risk factors among Chinese patients with type 2 diabetes mellitus. Methods: A cross-sectional study was conducted using data between November 1, 2018, and December 31, 2022. PAD was defined as ABI <= 0.9. DPN diagnosis involved specialized physician assessments using questionnaires and vibration perception threshold tests. Logistic regression analysis was used to identify related factors. We also evaluated the association between the clustering of risk factors and disease incidence. Results: The study population comprised 13,315 patients (mean age: 63.3 years). 4.9 % of the patients had PAD and 43.9 % had DPN. Multivariate regression analysis revealed advanced age, smoking, hypertension, coronary heart disease, dyslipidemia, elevated HbA1c, and uric acid levels as independent risk factors for PAD. For DPN, independent risk factors included advanced age, female gender, hypertension, coronary heart disease, elevated total cholesterol, triglycerides, lipoprotein(a), fasting plasma glucose, HbA1c, alkaline phosphatase, cystatin C, albumin-to-creatinine ratio, and elevated homocysteine levels, whereas apolipoprotein A was a protective factor. The clustering of risk factors was prevalent and associated with higher disease risk. Conclusions: Our study contributed to identifying high-risk individuals and improving lower limb health among diabetic individuals.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [31] Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
    Jaiswal, Mamta
    Divers, Jasmin
    Dabelea, Dana
    Isom, Scott
    Bell, Ronny A.
    Martin, Catherine L.
    Pettitt, David J.
    Saydah, Sharon
    Pihoker, Catherine
    Standiford, Debra A.
    Dolan, Lawrence M.
    Marcovina, Santica
    Linder, Barbara
    Liese, Angela D.
    Pop-Busui, Rodica
    Feldman, Eva L.
    DIABETES CARE, 2017, 40 (09) : 1226 - 1232
  • [32] Lipid risk factors for peripheral vascular disease in patients with Type 2 diabetes
    Best, JD
    ONeal, DN
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 306 - 306
  • [33] Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
    El-Haggar, Sahar Mohamed
    Hafez, Yasser Mostafa
    El Sharkawy, Amira Mohamed
    Khalifa, Maha
    MEDICINA CLINICA, 2024, 163 (02): : 53 - 61
  • [34] Risk of peripheral artery disease according to diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes
    Kallio, M.
    Harjutsalo, V.
    Forsblom, C.
    Groop, P. -H.
    DIABETOLOGIA, 2018, 61 : S552 - S552
  • [35] Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients
    Wu, Fan
    Jing, Yuanyuan
    Tang, Xiaojun
    Li, Dai
    Gong, Lilin
    Zhao, Hongyan
    He, Li
    Li, Qifu
    Li, Rong
    ACTA DIABETOLOGICA, 2017, 54 (10) : 925 - 931
  • [36] Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients
    Fan Wu
    Yuanyuan Jing
    Xiaojun Tang
    Dai Li
    Lilin Gong
    Hongyan Zhao
    Li He
    Qifu Li
    Rong Li
    Acta Diabetologica, 2017, 54 : 925 - 931
  • [37] Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
    Yang, Ruotong
    Yu, Huan
    Wu, Junhui
    Chen, Hongbo
    Wang, Mengying
    Wang, Siyue
    Qin, Xueying
    Wu, Tao
    Wu, Yiqun
    Hu, Yonghua
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes
    Pai, Yen-Wei
    Lin, Ching-Heng
    Lee, I-Te
    Chang, Ming-Hong
    DIABETES & METABOLISM, 2018, 44 (02) : 129 - 134
  • [39] Association of serum adropin with risk and severity of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
    Nearmeen M. Rashad
    Hanan M. Sabry
    Samir A. Afifi
    Maha A. Fathy
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 856 - 867
  • [40] Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
    Ko, Seung-Hyun
    Cha, Bong-Yun
    DIABETES & METABOLISM JOURNAL, 2012, 36 (01) : 6 - 12